Skip to Main Content

Paper Details

Convergent Clonal Evolution of Signaling Gene Mutations Is a Hallmark of Myelodysplastic Syndrome Progression.
Blood Cancer Discov
11
2022
AML, MDS, Myelodysplastic Syndrome, Signaling Gene, Signaling gene, acute myeloid leukemia, coexisting subclones, myelodysplastic syndromes, patient, patients, secondary AML, signaling gene, signaling gene mutation, subclones
Author NameAffiliation
Christopher A MillerWashington University School of Medicine
Michelle O'LaughlinMcDonnell Genome Institute, Washington University School of Medicine
Catrina FronickMcDonnell Genome Institute, Washington University School of Medicine
Robert S FultonMcDonnell Genome Institute, Washington University School of Medicine
Robert S FultonMcDonnell Genome Institute, Washington University School of Medicine
Sharon E HeathWashington University School of Medicine
David H SpencerWashington University School of Medicine
David H SpencerSiteman Cancer Center, Washington University School of Medicine
Jacqueline E PaytonSiteman Cancer Center, Washington University School of Medicine
Jacqueline E PaytonWashington University School of Medicine
Peter WesterveltWashington University School of Medicine
Peter WesterveltSiteman Cancer Center, Washington University School of Medicine
John F DiPersioWashington University School of Medicine
John F DiPersioSiteman Cancer Center, Washington University School of Medicine
Daniel C LinkWashington University School of Medicine
Daniel C LinkSiteman Cancer Center, Washington University School of Medicine
Timothy J LeyWashington University School of Medicine
Timothy J LeySiteman Cancer Center, Washington University School of Medicine
Matthew J WalterWashington University School of Medicine
Matthew J WalterSiteman Cancer Center, Washington University School of Medicine
  • 1 - 20

Datasets

Release 1.2